Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-mutated metastatic non-small cell lung cancer (NSCLC): Interim results of DESTINY-Lung01 Meeting Abstract
| Authors: | Smit, E. F.; Nakagawa, K.; Nagasaka, M.; Felip, E.; Goto, Y.; Li, B. T.; Pacheco, J. M.; Murakami, H.; Barlesi, F.; Saltos, A. N.; Perol, M.; Udagawa, H.; Saxena, K.; Shiga, R.; Guevara, F. M.; Acharyya, S.; Shahidi, J.; Planchard, D.; Janne, P. A. |
| Abstract Title: | Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-mutated metastatic non-small cell lung cancer (NSCLC): Interim results of DESTINY-Lung01 |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368303409 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.9504 |
| Notes: | Meeting Abstract: 9504 -- Source: Wos |
